These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 22989368)

  • 41. Misclassification of Aggressive Basal Cell Carcinoma Subtypes and Implications for Management.
    Moon D; Randall G; Higgins S; Sutton AV; Wysong A
    Dermatol Surg; 2021 May; 47(5):593-598. PubMed ID: 33905389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retrospective analysis of basal cell carcinoma.
    Hakverdi S; Balci DD; Dogramaci CA; Toprak S; Yaldiz M
    Indian J Dermatol Venereol Leprol; 2011; 77(2):251. PubMed ID: 21393972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
    Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
    Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pigmented basal cell carcinoma: investigation of 70 cases.
    Maloney ME; Jones DB; Sexton FM
    J Am Acad Dermatol; 1992 Jul; 27(1):74-8. PubMed ID: 1377719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
    Berk DR; Ball Arefiev KL; Gladstone HB
    Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Margin involvement and clinical pattern of basal cell carcinoma with mixed histology.
    Betti R; Radaelli G; Crosti C; Ghiozzi S; Moneghini L; Menni S
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):483-7. PubMed ID: 21545546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Basal cell carcinoma induced by therapeutic radiation for tinea capitis-clinicopathological study.
    Oshinsky S; Baum S; Huszar M; Debby A; Barzilai A
    Histopathology; 2018 Jul; 73(1):59-67. PubMed ID: 29464746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens.
    Swetter SM; Boldrick JC; Pierre P; Wong P; Egbert BM
    J Cutan Pathol; 2003 Feb; 30(2):139-46. PubMed ID: 12641794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
    Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
    Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype.
    Scrivener Y; Grosshans E; Cribier B
    Br J Dermatol; 2002 Jul; 147(1):41-7. PubMed ID: 12100183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in Rate of Complete Excision of Basal Cell Carcinoma by Dermatologists, Plastic Surgeons and General Practitioners: A Large Cross-Sectional Study.
    Ramdas K; van Lee C; Beck S; Bindels P; Noordhoek Hegt V; Pardo L; Versnel S; Nijsten T; van den Bos R
    Dermatology; 2018; 234(3-4):86-91. PubMed ID: 30086541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
    Bartoš V; Kullová M
    Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subtyping basal cell carcinoma by clinical diagnosis versus punch biopsy.
    Roozeboom MH; Kreukels H; Nelemans PJ; Mosterd K; Winnepenninckx VJ; Abdul Hamid MA; de Haas ER; Kelleners-Smeets NW
    Acta Derm Venereol; 2015 Nov; 95(8):996-8. PubMed ID: 25881552
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California.
    Wrone DA; Swetter SM; Egbert BM; Smoller BR; Khavari PA
    J Am Acad Dermatol; 1996 Dec; 35(6):907-10. PubMed ID: 8959949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Giant superficial basal cell carcinoma of the scrotum.
    Handa Y; Kato Y; Ishikawa H; Tomita Y
    Eur J Dermatol; 2005; 15(3):186-8. PubMed ID: 15908305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
    Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
    Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anatomic location of Basal cell carcinomas may favor certain histologic subtypes.
    Betti R; Radaelli G; Bombonato C; Crosti C; Cerri A; Menni S
    J Cutan Med Surg; 2010; 14(6):298-302. PubMed ID: 21084023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.